{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:07Z","timestamp":1790803267498,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>This review aimed to evaluate the efficacy and safety of intense pulsed light treatment combined with meibomian gland expression treatments in meibomian gland dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a meta-analysis of randomized controlled trials that compared the efficacy of intense pulsed light treatment and meibomian gland expression treatments in the treatment of dry eye disease. The meibomian gland yielding secretion score was the primary outcome, whereas the secondary outcomes included the Meiboscore, tear breakup time in seconds, standard patient evaluation for eye dryness and corneal fluorescein staining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study consisted of 6 trials with 326 patients. Significantly greater improvement was observed in meibomian gland yielding secretion score at 1 month [mean difference (MD): 13.69 (95% CI, 11.98, 15.40)] and at 3 months [MD: 11.03 (95% confidence interval (CI), 10.27, 11.80)], low meibomian gland yielding secretion score at 1 month [MD: 6.92 (95% CI, 5.49, 8.34)] and at 3 months [MD: 6.80 (95% CI, 5.01, 8.59)], up meibomian gland yielding secretion score at 1 month [MD: 6.41 (95% CI, 4.12, 8.70)] and at 3 months [MD: 8.06 (95% CI, 5.70, 10.42)] and tear breakup time at 1 month [MD: 2.38 (95% CI, 1.83, 2.92)] and at 3 months [MD: 1.82 (95% CI, 1.48, 2.19)] in the IPL-MGX group than in the MGX group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>IPL-MGX is safer and more efficacious as compared to the MGX alone in the treatment of patients with meibomian gland dysfunction-related dry eye. We recommend discussing the decision with the ophthalmologist for an appropriate choice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032292","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T14:07:44Z","timestamp":1672150064000},"page":"e32292","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of intense pulsed light and meibomian gland expression treatments in meibomian gland dysfunction: A meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-0362","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtos.2017.05.005","article-title":"TFOS DEWS II introduction.","volume":"15","author":"Nelson","year":"2017","journal-title":"Ocul Surf"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report.","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"DES7Des7","DOI":"10.1167\/iovs.17-23475","article-title":"Definition and diagnostic criteria of dry eye disease: historical overview and future directions.","volume":"59","author":"Shimazaki","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1556\/650.2018.31077","article-title":"[New international consensus statement about the definition, classification, ethiology, diagnostics and therapy of dry eye (TFOS DEWS II)].","volume":"159","author":"Berta","year":"2018","journal-title":"Orv Hetil"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1167\/iovs.10-6997h","article-title":"The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee.","volume":"52","author":"Asbell","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee.","volume":"52","author":"Nelson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/1081597X-20161006-05","article-title":"Effectiveness of an eyelid thermal pulsation procedure to treat recalcitrant dry eye symptoms after laser vision correction.","volume":"33","author":"Schallhorn","year":"2017","journal-title":"J Refract Surg"},{"key":"R10-20250504","first-page":"176","article-title":"Dermatologic lasers in the treatment of aging skin.","volume":"18","author":"Lipozen\u010di\u0107","year":"2010","journal-title":"Acta Dermatovenerol Croat"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000328264","article-title":"Vascular lesions.","volume":"42","author":"Ting","year":"2011","journal-title":"Curr Probl Dermatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ICU.0000000000000166","article-title":"Intense pulsed light therapy for the treatment of evaporative dry eye disease.","volume":"26","author":"Vora","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"R13-20250504","doi-asserted-by":"crossref","DOI":"10.3791\/57811","article-title":"Intense pulsed light for the treatment of dry eye owing to meibomian gland dysfunction.","author":"Vigo","year":"2019","journal-title":"J Vis Exp"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2147\/OPTH.S130706","article-title":"Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction.","volume":"11","author":"Dell","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1167\/iovs.14-15764","article-title":"Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction.","volume":"56","author":"Craig","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report.","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","article-title":"Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction.","volume":"17","author":"Arita","year":"2018","journal-title":"Ocul Surf"},{"key":"R18-20250504","first-page":"675","article-title":"Evaluation of short-term effect of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction.","volume":"53","author":"Rong","year":"2017","journal-title":"[Zhonghua yan ke za zhi] Chinese J Ophthalmol"},{"key":"R19-20250504","article-title":"The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a multicenter, randomized controlled trial.","author":"Yan","year":"2020","journal-title":"Eye Contact Lens"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/pho.2017.4402","article-title":"Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction.","volume":"36","author":"Rong","year":"2018","journal-title":"Photomed Laser Surg"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/pho.2018.4499","article-title":"Long-term effects of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction.","volume":"36","author":"Rong","year":"2018","journal-title":"Photomed Laser Surg"},{"key":"R22-20250504","article-title":"Efficacy comparison of intense pulsed light combined with meibomian gland massage and eyelid fumigation massage in the treatment of MGD\u2013related dry eyes.","volume":"19","author":"Dai","year":"2019","journal-title":"Int Eye Sci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/pho.2014.3819","article-title":"Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study.","volume":"33","author":"Toyos","year":"2015","journal-title":"Photomed Laser Surg"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis.","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/09286580600801044","article-title":"The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists.","volume":"13","author":"Clegg","year":"2006","journal-title":"Ophthalmic Epidemiol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"e37711","DOI":"10.1371\/journal.pone.0037711","article-title":"Cost of dry eye treatment in an Asian clinic setting.","volume":"7","author":"Waduthantri","year":"2012","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:22:42Z","timestamp":1746336162000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":28,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032292","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]}}}